Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Variation in the RAD51 gene and familial breast cancer.

Lose F, Lovelock P, Chenevix-Trench G, Mann GJ, Pupo GM, Spurdle AB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer..

Breast Cancer Res. 2006;8(3):R26. Epub 2006 Jun 8.

2.

RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population.

Jara L, Acevedo ML, Blanco R, Castro VG, Bravo T, Gómez F, Waugh E, Peralta O, Cabrera E, Reyes JM, Ampuero S, González-Hormazábal P.

Cancer Genet Cytogenet. 2007 Oct 1;178(1):65-9.

PMID:
17889711
3.

Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland.

Jakubowska A, Narod SA, Goldgar DE, Mierzejewski M, Masojć B, Nej K, Huzarska J, Byrski T, Górski B, Lubiński J.

Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):457-9.

4.

Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility.

Ding SL, Yu JC, Chen ST, Hsu GC, Kuo SJ, Lin YH, Wu PE, Shen CY.

Carcinogenesis. 2009 Jan;30(1):43-9. doi: 10.1093/carcin/bgn233. Epub 2008 Oct 28.

PMID:
18974064
5.

BCoR-L1 variation and breast cancer.

Lose F, Arnold J, Young DB, Brown CJ, Mann GJ, Pupo GM; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer., Khanna KK, Chenevix-Trench G, Spurdle AB.

Breast Cancer Res. 2007;9(4):R54. Erratum in: Breast Cancer Res. 2008;10(5):406.

6.

Screening for RAD51 and BRCA2 BRC repeat mutations in breast and ovarian cancer families.

Rapakko K, Heikkinen K, Karppinen SM, Winqvist R.

Cancer Lett. 2006 May 8;236(1):142-7. Epub 2005 Jul 11.

PMID:
16005565
7.

The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers.

Jakubowska A, Gronwald J, Menkiszak J, Górski B, Huzarski T, Byrski T, Edler L, Lubiñski J, Scott RJ, Hamann U.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):270-5.

8.

Genetic instability in the RAD51 and BRCA1 regions in breast cancer.

Nowacka-Zawisza M, Bryś M, Romanowicz-Makowska H, Kulig A, Krajewska WM.

Cell Mol Biol Lett. 2007;12(2):192-205. Epub 2006 Dec 18.

PMID:
17180310
9.

Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.

Nowacka-Zawisza M, Brys M, Romanowicz-Makowska H, Kulig A, Krajewska WM.

Pathol Int. 2008 May;58(5):275-81. doi: 10.1111/j.1440-1827.2008.02223.x.

PMID:
18429825
11.

Identification of Rad51 alteration in patients with bilateral breast cancer.

Kato M, Yano K, Matsuo F, Saito H, Katagiri T, Kurumizaka H, Yoshimoto M, Kasumi F, Akiyama F, Sakamoto G, Nagawa H, Nakamura Y, Miki Y.

J Hum Genet. 2000;45(3):133-7.

PMID:
10807537
12.
13.

Analysis of the G/C polymorphism in the 5'-untranslated region of the RAD51 gene in breast cancer.

Blasiak J, Przybyłowska K, Czechowska A, Zadrozny M, Pertyński T, Rykała J, Kołacińska A, Morawiec Z, Drzewoski J.

Acta Biochim Pol. 2003;50(1):249-53.

14.

The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer.

Söderlund K, Skoog L, Fornander T, Askmalm MS.

Radiother Oncol. 2007 Sep;84(3):242-51. Epub 2007 Aug 17.

PMID:
17707537
15.

Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.

Lewis AG, Flanagan J, Marsh A, Pupo GM, Mann G, Spurdle AB, Lindeman GJ, Visvader JE, Brown MA, Chenevix-Trench G; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer..

Breast Cancer Res. 2005;7(6):R1005-16. Epub 2005 Oct 21.

16.
17.

Altered DNA binding by the human Rad51-R150Q mutant found in breast cancer patients.

Ishida T, Takizawa Y, Sakane I, Kurumizaka H.

Biol Pharm Bull. 2007 Aug;30(8):1374-8.

18.

Analysis of RAD51 polymorphism and BRCA1 mutations in Polish women with breast cancer.

Romanowicz-Makowska H, Smolarz B, Zadrozny M, Kulig A.

Exp Oncol. 2006 Jun;28(2):156-9.

PMID:
16837909
19.

Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer.

Desjardins S, Beauparlant JC, Labrie Y, Ouellette G, Durocher F; INHERIT BRCAs..

BMC Cancer. 2009 Jun 12;9:181. doi: 10.1186/1471-2407-9-181.

20.

Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer.

Krupa R, Synowiec E, Pawlowska E, Morawiec Z, Sobczuk A, Zadrozny M, Wozniak K, Blasiak J.

Exp Mol Pathol. 2009 Aug;87(1):32-5. doi: 10.1016/j.yexmp.2009.04.005. Epub 2009 May 6.

PMID:
19426727

Supplemental Content

Support Center